Shire Newsroom: Media, News & Press Releases

09/21/2018
Rule 2.9 announcement
09/21/2018
Shire Receives Approval of FIRAZYR(R) (icatibant injection) for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan
09/20/2018
Health Canada has authorized TAKHZYRO(TM) (lanadelumab injection), a first-of-its-kind monoclonal antibody treatment for the prevention of hereditary angioedema (HAE) attacks
09/20/2018
Santé Canada autorise TAKHZYRO(MC) (lanadelumab en injection), le premier traitement à anticorps monoclonal en son genre destiné à la prévention de crises d’angioœdème héréditaire (AOH)
09/20/2018
Rule 2.9 announcement
09/19/2018
Rule 2.9 announcement
09/18/2018
Rule 2.9 announcement
09/17/2018
Rule 2.9 announcement
09/14/2018
Rule 2.9 Announcement
09/13/2018
Rule 2.9 announcement
09/12/2018
Rule 2.9 Announcement
09/12/2018
Shire granted EU marketing authorization for VEYVONDI® [vonicog alfa, recombinant von Willebrand factor] for adults with von Willebrand disease
09/11/2018
Rule 2.9 announcement
09/10/2018
Shire announces the pricing terms and increase in the maximum tender amount of the previously announced cash tender offers for certain outstanding notes
09/10/2018
Shire announces early results of the previously announced cash tender offers for certain outstanding notes
09/10/2018
Elections for the interim dividend in respect of the six months to June 30, 2018
09/06/2018
Shire Acquires sanaplasma AG Boosting Plasma Collection Network for Immunology Franchise
09/06/2018
Rule 2.9 announcement
09/04/2018
Rule 2.9 announcement
09/03/2018
Total Voting Rights
09/03/2018
Rule 2.9 announcement
08/31/2018
Shire Completes Sale of Oncology Franchise
08/31/2018
Rule 2.9 announcement
08/30/2018
Rule 2.9 announcement
08/29/2018
Rule 2.9 announcement

Media Contacts

External Communications

Katie Joyce
Communications & Public Affairs
KJoyce@shire.com

For All International Inquiries

Deborah Hibbett
Communications & Public Affairs
dhibbett@shire.com

Kirsty Langton
Communications & Public Affairs
kirsty.langton@shire.com

In This Section

Media Library

Learn more

Social Media

Learn more

Committed To Responsibility

We make decisions that put patients first.

Learn more

Shire Global

Europe

Americas

Asia Pacific

OVERVIEW

RECENT ACQUISITIONS

PRESENTATIONS AND REPORTS

TAKEDA'S OFFER

INVESTOR TOOLS

Shire

Newsroom

Media Contacts

External Communications

For All International Inquiries

Media Library

Social Media

Committed To Responsibility

Subscribe to Shire News Alerts

Cookie Use Notification

Confirm Navigation